Nuwellis (CHFS) Stock Price, News & Analysis

Company Overview

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Key Stats

• Today's Range: $5.00 to $5.32
• 50-Day Range: $3.53 to $6.02
• 52-Week Range: $4.86 to $37.50
• Volume: 61,173 shs
• Average Volume: 467,323 shs
• Market Capitalization: $31.51 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CHFS Stock Analysis - Frequently Asked Questions

How were Nuwellis' earnings last quarter?

Nuwellis, Inc. (NASDAQ:CHFS) posted its earnings results on Monday, March, 1st. The company reported ($1.57) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($1.91) by $0.34. The company earned $2.04 million during the quarter. Nuwellis had a negative net margin of 254.26% and a negative trailing twelve-month return on equity of 173.61%.

When did Nuwellis' stock split?

Nuwellis shares reverse split on Friday, October 13th 2017.The 1-20 reverse split was announced on Thursday, October 12th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 12th 2017. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Nuwellis own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuwellis investors own include Tonix Pharmaceuticals (TNXP), T2 Biosystems (TTOO), Biocept (BIOC), VBI Vaccines (VBIV), Prima BioMed (IMMP), NightHawk Biosciences (NHWK) and Sorrento Therapeutics (SRNE).

Company Calendar

• Last Earnings: 3/01/2021
• Today: 8/23/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical Equipment
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CHFS
• Previous Symbol: NASDAQ:SSH
• CIK: 1506492
• Web: www.chf-solutions.com
• Phone: (952) 345-4200
• Fax: N/A
• Employees: 66
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($279.28)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$18.11 million
• Net Margins: -254.26%
• Pretax Margin: N/A
• Return on Equity: -173.61%
• Return on Assets: -131.01%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 6.87
• Quick Ratio: 5.97

Sales & Book Value

• Annual Sales: $5.51 million
• Price / Sales: 5.72
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $12.79 per share
• Price / Book: 0.41

Miscellaneous

• Outstanding Shares: 6,037,000
• Free Float: N/A
• Market Cap: $31.51 million
• Optionable: Not Optionable
• Beta: 1.55